Our latest campaign is focused on helping ensure vets and military personnel receive therapeutic mental health care. Listen to K9s for Veterans founder, Michael Tellerino, and Wendy Dolin discuss this collaboration and the need for akathisia awareness on our recent podcast. See the full release at https://www.einpresswire.com/article/671027397/missd-seeks-support-to-combat-akathisia-and-save-lives and take a sneak peek of our upcoming public health video.

Dear Friends of MISSD,

It’s Giving Tuesday–one of the most significant giving days of the year. Can we count on you to make a tax-deductible contribution to help us reduce suffering and save lives?

Your support enables MISSD to increase akathisia awareness, provide free educational resources, and expand our reach. One example is our latest campaign aimed at helping veterans receive therapeutic care. Our recent press release offers a sneak peek of this upcoming video and a new podcast interview with K9s for Veterans founder Michael Tellerino and me. The informative and profoundly moving stories underscore the importance of our mission. See https://www.einpresswire.com/article/667671324/raising-awareness-of-akathisia-and-suicide-risks-among-veterans. 

If you’ve already made your Giving Tuesday gift, thank you. If you haven’t, please take a minute to join us in making a positive difference for others. Your donations are more than just contributions; they are lifelines that empower us to continue our work. 

With gratitude–Wendy Dolin and the MISSD Team

The Texas Attorney General’s office sues Pfizer over ADHD drug, Quillivant–which can cause serious adverse effects to include akathisia, mania & sexual dysfunction.

“I am horrified by the dishonesty we uncovered in this investigation,” said Texas AG Ken Paxton. Pfizer “intentionally concealed and failed to disclose the issues with Quillivant to receive taxpayer-funded benefits through Texas Medicaid, defrauding the state and endangering children.” Read the article at https://www.foxbusiness.com/politics/texas-ag-sues-pfizer-allegedly-selling-medicine-knew-ineffective-manipulated-quality-test-results. Read the adverse effects of Quillivant at https://www.rxlist.com/quillivant-xr-drug.htm#warnings.

We’re pleased to announce our latest awareness campaign focuses on veterans and the military and kicks off today with a new Akathisia Stories episode. The campaign includes targeted military base ads, and a compelling public health video in which veterans share first-hand accounts of akathisia-induced suicidality. Read more at https://www.einpresswire.com/article/667671324/raising-awareness-of-akathisia-and-suicide-risks-among-veterans and listen to the podcast interview with Wendy Dolin and K9s for Veterans founder, Michael Tellerino at https://www.studiocchicago.com/akathisia-stories.

The public is becoming increasingly aware of adverse effects some people suffer long after discontinuing SSRIs. This NY Times article covers PSSD. We’d like to see an article published about withdrawal akathisia next. Read the full article at https://www.nytimes.com/2023/11/09/health/antidepressants-ssri-sexual-dysfunction.html?fbclid=IwAR3XQ3lSo4feRqsRRgQZzYYNOvJxyO_tRn8fVqzdfADuk4UW8Jt395wxga8.

Dr. Dennis Miller, is a retired chain store pharmacist, and author of The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, has written an excellent article listing 25 things the FDA can do to improve patient safety and regain public trust. Read them at https://www.peoplespharmacy.com/articles/25-things-fda-must-do-to-rebuild-its-reputation.

The UK has issued new risk warnings & prescribing regulations for the acne drug, Isotretinoin (Roaccutane). They include additional treatment oversight for consumers under 18. This drug can cause sexual dysfunction, akathisia-induced violence, self-harm & suicide. Read the full article at https://www.gov.uk/drug-safety-update/isotretinoin-roaccutanev-introduction-of-new-safety-measures-including-additional-oversight-of-the-initiation-of-treatment-for-patients-under-18-years-of-age.